The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy

Author: Schäfer S.   Linz W.   Vollert H.   Biemer-Daub G.   Rütten H.   Bleich M.   Busch A.  

Publisher: Springer Publishing Company

ISSN: 0012-186X

Source: Diabetologia, Vol.47, Iss.1, 2004-01, pp. : 98-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content